Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA2670)
A highly specific and potent tool for your biotech research needs.
This antibody targets the CD261/TNFRSF10A/DR4 protein, a member of the tumor necrosis factor (TNF) receptor superfamily. CD261/TNFRSF10A/DR4 is a cell surface receptor that plays a crucial role in the regulation of apoptosis, or programmed cell death. It is involved in various cellular processes, including immune response, tissue development, and maintenance of homeostasis.
The Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA2670) has been extensively tested and validated for its high specificity and sensitivity towards the CD261/TNFRSF10A/DR4 protein. It has been shown to effectively block the binding of TNF-related apoptosis-inducing ligand (TRAIL) to CD261/TNFRSF10A/DR4, thereby inhibiting the apoptotic signaling pathway.
This antibody is a valuable tool for studying the role of CD261/TNFRSF10A/DR4 in various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. It can also be used to investigate the therapeutic potential of targeting CD261/TNFRSF10A/DR4 in these conditions.
The Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA2670) has been successfully used in a variety of experimental techniques, including western blotting, immunoprecipitation, and immunofluorescence. Its high specificity and sensitivity make it an ideal choice for detecting and quantifying CD261/TNFRSF10A/DR4 expression in different cell types and tissues.
In summary, the Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA2670) is a reliable and powerful tool for studying the function of CD261/TNFRSF10A/DR4 in various biological processes. Its applications range from basic research to potential therapeutic interventions, making it a valuable addition to any biotech laboratory. Order now and advance your research with confidence.
There are no reviews yet.